JAIDS Journal of Acquired Immune Deficiency Syndromes 2014-12-15

Risk reduction with buprenorphine-naloxone and methadone: patient's choice.

Robert G Newman

Index: J. Acquir. Immune Defic. Syndr. 67(5) , e142, (2014)

Full Text: HTML

Structure	Name/CAS No.	Molecular Formula	Articles
	Formaldehyde hydrochloride (1:1) CAS:1095-90-5	CH₃ClO
	(+/-)-METHADONE CAS:76-99-3	C₂₁H₂₄D₃NO
	buprenorphine hydrochlorie CAS:53152-21-9	C₂₉H₄₂ClNO₄
	Naloxone hydrochloride dihydrate CAS:51481-60-8	C₁₉H₂₆ClNO₆
	buprenorphine CAS:52485-79-7	C₂₉H₄₂ClNO₄

Differentiation between human ClC-2 and CFTR Cl- channels wi...
2014-09-01
[Am. J. Physiol. Cell Physiol. 307(5) , C479-92, (2014)]

Cyclosporine-inhibitable cerebral drug transport does not in...
2014-12-01
[Anesthesiology 121(6) , 1281-91, (2014)]

Disaccharides in urine samples as markers of intravenous abu...
2013-01-01
[J. Anal. Toxicol. 37(9) , 652-8, (2013)]

[Treatment of chronic hepatitis C in drug users: ethic, succ...
2014-12-01
[Presse Med. 43(12 Pt 1) , 1314-6, (2014)]

Methadone is a local anaesthetic-like inhibitor of neuronal ...
2015-01-01
[Br. J. Anaesth. 114(1) , 110-20, (2015)]